CervoMed Inc reports results for the quarter ended March 31 - Earnings Summary

• CervoMed Inc CRVO.OQ reported a quarterly adjusted loss of 56 cents​​ per share for the quarter ended March 31, lower than the same quarter last year, when the company reported EPS of -41 cents. The mean expectation of seven analysts for the quarter was for a loss of 66 cents per share. Wall Street expected results to range from -80 cents to -57 cents per share.

• Revenue fell 18.3% to $1.92 million from a year ago; analysts expected $1.72 million.

• CervoMed Inc's reported EPS for the quarter was a loss of 56 cents​.

• The company reported a quarterly loss of $4.89 million.

• CervoMed Inc shares had fallen by 7.2% this quarter and gained 262.8% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 14.1% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

• Wall Street's median 12-month price target for CervoMed Inc is $15.00

This summary was machine generated from LSEG data May 12 at 09:00 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)